Amgen is purchasing Five Prime Therapeutics for about $1.9 billion
Amgen is purchasing Five Prime Therapeutics for about $1.9 billion to grow the reach its line of gastric cancer growth
Read moreAmgen is purchasing Five Prime Therapeutics for about $1.9 billion to grow the reach its line of gastric cancer growth
Read more